Feature | Thrombectomy Devices | September 02, 2015

Larger Thrombi Retrieval Associated with Improved Neurological Recovery After Stroke

Sub-study of MR CLEAN trial suggests that retrieving larger thrombi may be better than retrieving large numbers of smaller particles

acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study

September 2, 2015 — Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery after acute ischemic stroke, according to a sub-study of the MR CLEAN trial. Results of the sub-study were presented at the European Society of Cardiology (ESC) Congress 2015 by Anouchska Autar, Ph.D. candidate at the Erasmus Medical Centre in Rotterdam, the Netherlands.

“Acute ischemic strokes occur when a blood clot, also called a thrombus, embolizes to the brain where it restricts the flow of blood,” said Autar. “MR CLEAN was the first trial to show the benefit of IAT to remove blood clots within six hours after a stroke. IAT, which was given against a background of standard care including intravenous tissue plasminogen activator if indicated, led to better restoration of blood flow and improved functional outcome when compared to no IAT.”

Thrombi retrieved during the MR CLEAN trial were collected for the current sub-study to investigate the relationship between the macroscopic appearance of thrombi retrieved during IAT, cause of stroke and clinical outcome. Measures of macroscopic appearance included length, width, area and numbers of particles the thrombus had broken into.

Neurological recovery was assessed using the National Institutes of Health Stroke Severity Scale (NIHSS).

The study included 35 collections of thrombi from 35 patients who had undergone IAT after an acute ischemic stroke. Most of the patients had a severe stroke, of which 49 percent were of cardiac origin and 20 percent were due to atherosclerosis.

The researchers found that patients whose stroke was caused by atherosclerosis had significantly longer and larger thrombi (p=0.0035 and p=0.045, respectively) than those with stroke from other causes. “This could be because patients with atherosclerosis have more diseased arteries and this may influence thrombus size,” said Autar.

They also found that patients from whom longer and wider thrombi were retrieved had significantly improved neurological recovery at discharge after IAT compared to those with smaller thrombi (p=0.03 and p=0.04, respectively). “This finding is particularly important because it indicates that the larger the pieces that you retrieve, the better this is for your patient,” said Autar.

Interestingly, an increased number of particles retrieved during IAT showed a trend towards a worse neurological recovery at discharge, although the association was not significant (p=0.079). Autar said: “Together, this suggests that some emboli are more likely to disintegrate and the smaller particles may embolize and obstruct the microvasculature of the brain, leading to incomplete recovery.”

She concluded: “Our study shows that retrieval of larger thrombi during IAT is associated with improved neurological recovery at discharge in patients with acute ischemic stroke. The findings indicate that a simple parameter such as thrombus size might influence the decision to give or refrain from additional thrombolysis. This needs to be verified of course in larger trials.”

For more information: http://www.escardio.org/

Related Content

American College of Cardiology Expands Patient Navigator Program
News | Cath Lab | March 21, 2018
March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help impro
Videos | Cath Lab | March 15, 2018
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer
News | Cath Lab | February 27, 2018
The American College of Cardiology (ACC) and the Saudi Arabian Cardiac Interventional Society have partnered to...
News | Cath Lab | February 23, 2018
February 23, 2018 — CorFlow Therapeutics AG announced that the company will present new insights into the coronary mi
Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Overlay Init